Physician Wealth Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.39K Sell
58
-9
-13% -$502 ﹤0.01% 1295
2026
Q2
$3.65K Buy
67
+39
+139% +$1.9K ﹤0.01% 1240
2026
Q1
$1.2K Hold
28
– – ﹤0.01% 1574
2025
Q4
$1.23K Sell
28
-12
-30% -$496 ﹤0.01% 1511
2025
Q3
$1.65K Sell
40
-6
-13% -$241 ﹤0.01% 1313
2025
Q2
$2.03K Buy
46
+28
+156% +$1.12K ﹤0.01% 1040
2025
Q1
$665 Buy
+18
New +$641 ﹤0.01% 1298

Other funds holding EXEL

Physician Wealth Advisors's EXEL Position: Q3 2026 in Review

Physician Wealth Advisors reduced its Exelixis (EXEL) stake by 13% in Q3 2026, selling an estimated $502 and leaving 58 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.

Physician Wealth Advisors first reported a position in EXEL in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.65K in Q2 2026. 777 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • Physician Wealth Advisors held 58 shares of Exelixis worth $3.39K as of Q3 2026.
  • Physician Wealth Advisors sold 9 Exelixis shares in Q3 2026, an estimated $502.
  • Exelixis made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1295 holding.
  • Physician Wealth Advisors first reported a position in Exelixis in Q1 2025 and has held it in 7 quarters since.
  • Physician Wealth Advisors's Exelixis position peaked at $3.65K in Q2 2026.
  • 777 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.